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Introduction 
Acute Kidney Injury (AKI) after cardiac surgery 
is a serious complication. Depending on the 
definition used, up to 30% of cardiac surgery 
patients develop some form of AKI post-surgery, 
and 1-5% develop severe kidney injury 
necessitating dialysis (AKI-D) [1]. The mortality 
following AKI-D ranged between 50 and 80%. Even 
milder forms of AKI can impact short-term and 
long-term morbidity and mortality [2]. AKI 
associated with cardiac surgery increases 
infectious risk, extends the length of stay in the 
intensive care unit, thereby increasing health care 
resources and independently predicting death [3]. 
Recent advancements in cardiac surgery 
reduced mortality; however, the incidence of 
renal dysfunction has more or less remained the 
same. The goal is to predict AKI accurately, apply 
preventive measures, and early recognize and 
treat AKI [4]. There are few externally valid tools 
for risk stratification for AKI-D, such as the 
Cleveland Clinic Scoring tool and Mehta score 
[5,6]. The Cleveland Clinic Scoring tool tested a 
large cohort of patients (n = 15,838) to identify 
Vol. 3, No. 5, 121 - 127 
Abstract 
Background: Acute Kidney Injury (AKI) after cardiac surgery is a serious complication. 
AKI could occur in 30% of patients, and 1-5% develop severe kidney injury. The 
present study aimed to evaluate the use of the Cleveland Clinic Score (CCS) to 
identify patients at higher risk of AKI after cardiac surgery.  
Methods: This study included 100 patients, 83 were males, and the mean age was 
52.47±11.3 years. All patients had elective operations; 30% had isolated valve 
surgery, 64% had isolated coronary artery bypass grafting (CABG), and 6% had 
combined CABG and valve operation.  
Results: Creatinine serum level ranged between 0.5-2 mg/dL with a mean of 
0.98±0.32 mg/dL. Seventy-four patients had good renal function postoperatively, 
and their CCS was 1.45±0.36, while 26 patients had renal impairment, and their CCS 
was 12.5±0.44 (P= 0.001). Patients who had AKI were older (62.87±8.7 vs. 49.9±13.9; 
P<0.001) and had higher preoperative creatinine (1.1±0.32 vs. 0.94±0.31; P= 0.03). 
AKI was more common in diabetics (23 (88.5%) vs. 28 (37.85, P<0.001) and patients 
with COPD (6 (23.1%) vs. 3 (4.1%); P= 0.004). CCS score was significantly higher 
among the different degrees of severity of AKI.  
Conclusion: Cleveland Clinic Score could be good for predicting acute kidney injury 
after cardiac surgery. 
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patients at risk of developing AKI after open-
heart surgery [7,8]. The present study aimed to 
evaluate the use of the Cleveland Clinic Score 
(CCS) to identify patients at higher risk of AKI 
after cardiac surgery. 
Patients and methods: 
Design and patients: 
This research is a prospective cohort study that 
included 100 patients (≥18 yrs) who underwent 
open cardiac surgery. The study was conducted in 
the hospitals of Benha Faculty Medicine, 6th 
October Hospital for Health Insurance, National 
Heart Institute, and Nasser institute. The study 
was performed from May 2018 until July 2020. The 
patients were then divided (according to CCS) into 
four risk categories of increasing severity (scores 
0-2, 3-5, 6-8, and 9-≥13). 
Inclusion criteria were all adult patients who 
had elective cardiac surgery. Patients who 
required preoperative dialysis, patients with score 
(≥13), heart failure requiring extracorporeal 
membrane oxygenation (ECMO), preoperative 
tracheostomy, preoperative mechanical 
ventilation (MV), complicated procedures, and 
missing data and emergency cases, were excluded 
from the study. 
Eighty-three of our patients were males (83%). 
The age of patients ranged between 18 and 70 
years with a mean age of 52.47±11.3 years.  
Surgical techniques: 
Valve replacement 
Median sternotomy was performed, followed 
by the aorta and bicaval cannulation. Then 
cardiopulmonary bypass was started, the aorta 
was cross-clamped, cardioplegia was given 
(antegrade blood enriched intermittent cold 
crystalloid) or (warm blood enriched antegrade). 
Left atriotomy was done (or aortotomy), followed 
by removal of the diseased mitral (or aortic) valve 
(with or without preservation of posterior leaflet). 
We performed mitral valve replacement with 
interrupted 2/0 Ethibond sutures on Teflon 
pledgets. Aortic valve replacement was performed 
with interrupted 2/0 Ethibond sutures (on or 
without Teflon pledgets). This was followed by the 
closure of the left atriotomy (or aortotomy). 
Tricuspid valve repair was performed using 
DeVaga sutures through right atriotomy.  
Coronary artery bypass grafting (CABG) 
Median sternotomy was done, then we 
harvested the left internal mammary artery and 
left or right great saphenous vein. 
Cardiopulmonary bypass was started using aorta 
and single-stage venous cannula. The left internal 
mammary artery was anastomosed to the left 
anterior descending artery and venous grafts to 
the other targets.   
Data: 
All patients had a preoperative assessment, 
including history taking, complete clinical 
examination, full laboratory investigation, 
preoperative chest X-ray, electrocardiography 
(ECG), echocardiography (ECHO), and coronary 
angiography. 
Intraoperative data collected were 
cardiopulmonary bypass and aortic cross-clamp 
times, cardioplegia "type, number of doses," and 
inotropic support. Postoperative data included 
intensive care unit (ICU) stay, duration of 
mechanical ventilation, the need for inotropic use, 
echocardiographic findings, the need for renal 
replacement therapy, and the total hospital stay. 
Postoperative complications were reported, 
including re-exploration for bleeding, arrhythmia 
and myocardial infarction (MI), neurological 
complications such as transient ischemic attacks 
and/or cerebrovascular accident (CVA), 
pulmonary complications including pulmonary 
infection, atelectasis, re-intubation, and wound 
infection. 
Endpoints and definitions: 
The primary outcome was AKI as defined by 
the KDIGO (Kidney Diseases Improving Global 
Outcomes) criteria; stage 1, stage 2, or stage 3. 
Stage 1 was defined as an increase in serum 
creatinine 1.5–1.9 times the baseline within five 
days, stage 2 was an increase in creatinine 2.0–2.9 
times the baseline within five days, and stage 3 
was a documented increase of more than 3.0 
times the baseline or requirement or initiation of 
renal replacement therapy (RRT) during the 
hospital stay. Measurement of urine output was 
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avoided as it is frequently influenced by volume 
resuscitation and the administration of 
medications like diuretics, making it hard to assess 
dependably.  
To evaluate the use of the Cleveland Clinic 
Scoring tool, a score for each patient was 
calculated based on the general method 
described by Thakar and colleagues [5].  The 
Thakar model has been shown to offer the best 
discriminative value. It can be used in the 
preoperative setting and is appropriate for all 
patients undergoing cardiac surgery. 
The following point system was utilized: 
female gender: 1, congestive heart failure: 1, left 
ventricular ejection fraction <35%: 1, preoperative 
use of IABP: 2, COPD: 1, insulin-requiring diabetes: 
1, previous cardiac surgery: 1, emergency surgery: 
2, surgery type: CABG: 0, Valve only: 1, CABG + 
Valve: 2, Other cardiac surgeries: 2, preoperative 
creatinine: 1.2 to <2.1 mg/dl: 2, ≥2.1 mg/dl: 5. 
Risk scores are converted to estimated risk of 
dialysis with 0-2, 3-5, 6-8, 9-13 points had risk of 
dialysis of 0.4%, 1.8%, 7.8-9.5%, 21.5% 
respectively. Emergency surgeries were not 
included in the scoring tool. Thereby, the 
minimum score in our data set was 0, and the 
maximum score was 15. Patients were risk-
stratified as per the score into low-risk (score 0–
2), intermediate-risk (3–5), and high risk (≥6) 
groups as described in the original study. 
Statistical analysis 
Descriptive statistics were provided as 
frequency (%) for categorical variables, whereas 
continuous variables were presented as means 
(standard deviation). Categorical variables were 
compared between AKI patients and non-AKI 
patients with Chi-square or Fischer exact test if 
appropriate. Continuous variables have been 
compared using the t-test or Mann-Whitney test. 
The score was compared between more than two 
groups using one-way ANOVA. All statistical tests 
were double-sided with a threshold of alpha of 
0.05 for statistical relevance. STATA version 11.0 
SE was used for statistical analyses (StataCorp LP, 
College Station, TX, USA). 
Results: 
Patients' height ranged between 155-185 cm 
with a mean height of 172.16± 6.83 cm. The 
patients' weight ranged between 50-125 kg with 
a mean weight of 87.12 ± 17.31 kg. On 
echocardiographic examination, seventy-three of 
our patients had good ejection fractions, 26 had a 
fair ejection fraction, and one had a poor ejection 
fraction. Creatinine serum level ranged between 
0.5-2 mg/dL with a mean of 0.98±0.32 mg/dL.
Heart failure was present in three patients (3%). 
Chronic lung diseases were present in 9% of 
patients. Thirty patients had diabetes mellitus; 12 
were on oral antidiabetic drugs, and 18 were on 
insulin therapy. (Table 1) 
Table 1: Preoperative data. Categorical data were 
presented as numbers and percentages. 
All of our patients had elective surgery, and 
ninety-four of them had primary surgery. Most of 
our patients (91%) did not need intra-aortic 
balloon pump (IABP) insertion. Fourteen patients 
came off bypass with a minimal dose of inotropic 
support. Six patients needed a high dose of 
inotropic support. Postoperatively, all patients 
needed mechanical ventilation; three had 
prolonged mechanical ventilation. The period of 
mechanical ventilation ranged between 4-72 
hours with a mean period of 10.88 ± 8.04 hours 
(Table 2) 
During the early postoperative period, ninety-
two patients had a smooth course and did not 
need reoperation. Reoperation was needed in 
eight patients due to severe bleeding, cardiac 
tamponading, and mediastinitis. Most patients 
had good cardiac output postoperatively, while it 
was impaired in ten patients with a statistically 
Variable n= 100 
Ejection fraction 
Good 73 (73%) 
Fair 26 (26%) 
Poor 1 (1%) 
Renal impairment 4 (4%) 
Previous heart failure 3 (3%) 
Chronic lung disease 9 (9%) 
Diabetes Mellitus 30 (30%) 
Oral 12 (12%) 
Insulin 18 (18%) 
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significant difference.  Low cardiac output was due 
to arrhythmia, pericardial tamponade, and MI. 
(Table 2).  
Table 2: Operative and postoperative data 
Variable (n= 100) 
Primary operation 94 (94%) 
Redo 6 (6%) 




Period of mechanical ventilation 
(hours) [MeanSD] 
10.888.04 
Postoperative ICU (hours) 
[MeanSD] 
49.2636.7 
Postoperative renal impairment 26 (26%) 
Low cardiac output 10 (10%) 
Arrhythmia 5 (50%) 
Tamponade 3 (30%) 
Severe MI 2 (2%) 
Reoperation 8 (8%) 
Severe bleeding 2 (25%) 
Cardiac tamponade 5 (62.5%) 
Mediastinitis 1 (12.5%) 
ICU: intensive care unit, MI: myocardial 
infarction 
By comparing pre and perioperative risk 
variables in patients with and without AKI, all of 
these parameters (except gender) were 
significantly higher in patients who developed AKI 
(Table 3). CCS score was significantly higher 
among the different degrees of severity of AKI 
(Table 4). 
During the postoperative period, seventy-
three patients had a smooth postoperative course 
without complications, while twenty-seven had 
postoperative complications related to the wound 
site; the most frequent were superficial wound 
infections. The most common causes of death 
among six patients were cardiac failure and AKI. 
(Table 5) 
Discussion 
Multiple studies have found that the Cleveland 
Clinic Score (CCS) has the highest discriminative 
power in the Western population [9].  However, 
as the authors have stated, the model needed to 
be tested prospectively in multiple centers and 
heterogeneous populations to substantiate its 
broad applicability [10,11]. 
A key limitation of this risk score is the inability 
to predict milder forms of AKI, which may have 
significant and long-term effects. The purported 
reasons for AKI following cardiac surgery include 
renal ischemia-reperfusion injury, inflammation, 
athero-embolism, neurohormonal activation, and 
oxidative stress [12]. 
Though this is not equivocal, most of this data 
has been from the Western literature in a 
predominantly white and Caucasian population 
with no available data in the Egyptian population 
who may exhibit different clinical outcomes. The 
Egyptian population is probably the best suited to 
test the applicability of the scoring tool as Egypt 
has one of the highest rates of diabetes and 
cardiovascular disease in the developing world 
[9,13]. 
In our study, 3% had heart failure, 2% had 
chronic lung diseases, and 30% of our patients 
were diabetics on oral or insulin therapy. In their 
study, Rao and coworkers found diabetes mellitus 
and chronic obstructive pulmonary diseases 
(COPD) as risk factors for AKI postoperatively, 
which aligns with our study [14]. 
Kristovic and colleagues found that 28.8% had 
diabetes mellitus, 9% had COPD, and 14.5% had 
congestive heart failure [15]. Machado and 
coworkers found that about 23% of the patients 
were diabetics, which aligns with our study [16]. 
All of our patients had elective surgery, and 
94% of them had primary surgery. Weaning from 
cardiopulmonary bypass was smooth with or 
without minimal support with inotropes. These 
findings agree with other studies [15, 16]. 
Mechanical ventilation was used in 97% of 
patients postoperatively, and the mean period 
was about 11 hours mainly. Additionally, 90% of 
our patients had postoperative good cardiac 
output. The reoperation was required in 8% of the 
patients primarily due to postoperative bleeding, 
cardiac failure and/or mediastinitis. After 
discharge from ICU, the readmission to ICU was
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Table 3: Pre and perioperative risk variables in patients with and without postoperative acute kidney injury 
AKI (n=26) No AKI (n= 74) P-value 
Age (years) 62.87±8.7 49.9±13.9 <0.0001 
Male 24(92.3%) 59(79.7%) 0.14 
Preoperative IABP 5(19.2%) 4(5.4%) 0.03 
COPD 6(23.1%) 3(4.1%) 0.004 
DM 23(88.5%) 28(37.8%) <0.0001 
Previous cardiac surgery 5(19.2%) 1(1.4%) 0.005 
Surgery type 
CABG 51(68.9%) 13(50%) 
0.16 Valve only 20(27%) 10(38.5%) 
CABG + valve 3(4.1%) 3(11.5%) 
Preoperative creatinine (mg/dl) 1.1±0.32 0.94±0.31 0.03 
AKI: acute kidney injury, IABP: Intra-aortic balloon pump, COPD: chronic obstructive pulmonary disease, 
DM: diabetes mellitus, CABG: coronary artery bypass graft. Continuous data were presented as mean and 
standard deviation, and categorical data as numbers and percentages.  
Table 4: Cleveland Clinic Score in patients with different degrees of acute kidney injury 
Non-AKI (n= 74) Moderate AKI (n= 23) Severe AKI (n= 3) P value 
CCS score 1.3±0.4 4.2±0.35 10.55±0.33 0.01 
CCS: Cleveland clinical score, AKI: acute kidney injury 
needed in 3% of cases with a mean duration of 
two days. 
A similar study by Machado and colleagues 
found that only 12% of patients needed prolonged 
MV more than 24 hours, which runs in line with 
our study. Moreover, 80% of their patients had 
good postoperative cardiac functions, and the 
length of ICU stay ranged between 2-5 days with a 
mean of about two days which is consistent with 
our study [16]. 
Table 5: Postoperative outcome in patients of the study 
Variable (n= 100) 
Postoperative complications 
Superficial skin infection 21 (21%) 
Rocking sternum 2 (2%) 
Deep infection 4 (4%) 
Postoperative mortality 6 (6%) 
Cardiac failure 2 (33.3%) 
Severe PO bleeding 1 (16.7%) 
Mediastinitis 1 (16.7%) 
Acute kidney injury 2 (33.3%) 
Most of our patients had good renal function 
(74%), while 26% developed AKI. Patients who 
developed AKI showed significant CCS with 
significant perioperative variables. Ranucci and 
coworkers had an 8.2% incidence of AKI in 
patients who underwent cardiac surgery [17]. 
While Rao and colleagues found that the 
incidence of postoperatively AKI was 6.88% [14]. 
On the other hand, Pickering and colleagues 
had an 18.2% rate of AKI [18]. Several other 
studies found a different incidence of AKI. 
Kristovic and colleagues found an incidence of AKI 
of 3.6% [15]. The reported rate of AKI postcardiac 
surgery ranged from 5 to 50% [19-25]. 
Rao and coworkers found that the mean CCST 
scores were 1.6 in those without AKI, 1.5 in stage 
1, 3.0 in stage 2, and 3.4 in stage 3 AKI. Higher risk 
scores predicted a greater risk of AKI. Still, they 
found that mean age, gender, BMI, preoperative 
serum creatinine, diabetes mellitus, COPD, 
cardiopulmonary bypass time was similar in 
patients who developed AKI vs. those who did 
not have AKI postoperatively [14]. 
While Nuh and colleagues found that age, 
hypertension, diabetes mellitus, previous 
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myocardial infarction, left ventricular ejection 
fraction <30%, preoperative anemia, preoperative 
creatinine, eGFR ≤60 ml/min, type of surgery, and 
intraoperative use of IABP were risk factors for 
AKI. Additionally, AKI frequency increased with 
increase clinical score, which matches our finding 
[26]. 
Similarly, Liu and coworkers found that 
patients who developed post-cardiac surgery AKI 
had significant preoperative elevated serum 
creatinine. They confirmed that preoperative 
occult renal insufficiency was associated with 
elevated postoperative risk of AKI [27]. 
Postoperative complications occurred in 27% of 
our cases and mortality in 6% primarily due to 
cardiac failure, severe postoperative bleeding, and 
mediastinitis. Ranucci and coworkers found that 
the mortality rate was 1.3% in non-AKI patients 
and about 12.2% in patients with AKI, which 
agrees with our results [17]. Rao and colleagues 
found that the mortality rate was about 4% 
postoperatively [14]. Similarly, Jiang and 
coworkers reported a mortality rate of about 
6.1% postoperatively, coping with our study [24]. 
Pickering and colleagues found a pooled mortality 
rate of 2.2%, Machado and coworkers found a 
mortality rate of 2.2% in non-AKI patients and 
increase with the stage of AKI and a general 
mortality rate in all patients of about 7.1%, which 
agrees with what we found in our study [16,18]. 
Another study by Robert and colleagues found a 
mortality rate of 36.8% in advanced AKI and 14.2% 
in moderate AKI, while the mortality with mild 
AKI was 4.1%, which matches our finding [25]. In 
addition, De Santo and coworkers found a 
mortality rate of 5% in their study, which 
supports our results [28]. 
Strengths and limitations: 
The strength of this study was the multicenter 
design. The cohort of patients was well 
represented in age, sex, and type of surgery, 
including CABG and valve surgery. Our model 
incorporated both preoperative and 
intraoperative components, offering more exact 
risk stratification for AKI advancement. This gave a 
management tool for doctors to distinguish high-
risk patients so that early management strategies 
can be established. 
A limitation of this study was the utilization of 
serum creatinine to characterize AKI. The current 
tests and criteria utilized for the determination of 
AKI might preclude early discovery of AKI. 
Diagnosis of AKI relied upon the increase in serum 
creatinine, which takes 12–48 h to accumulate. 
Serum levels increment solely after 50% or more 
of renal function was lost, and numerous elements 
could influence it. 
Conclusion 
Our study concludes that Cleveland Clinic 
Score could be a good score for predicting acute 
kidney injury after cardiac surgery. 
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